9 Comments
User's avatar
Ozeco's avatar

Loved this article and your nuanced view!

Expand full comment
Jodi Ware's avatar

Good observations re: Librela, Sir! 🫡

Expand full comment
Best Anchor Stocks's avatar

Thank you!

Expand full comment
Best Anchor Stocks's avatar

What's incredible is that this only happens in the US but has not been a concern in Europe? Rare!

Expand full comment
Jodi Ware's avatar

The majority of cases in and authors of this article are from Europe.

Expand full comment
Best Anchor Stocks's avatar

And yet you have Librela penetrating mild cases in Europe which would 100% not be the case if adverse effects were so widespread.

Expand full comment
Jodi Ware's avatar

I encourage you to read the full article (including supplementary materials).

Expand full comment
James's avatar

First off, amazing write up really appreciate your knowledge. One question for you: why has ZTS current ratio dropped the last 2 quarters? Was it accelerated buybacks as a result of share price declines?

Expand full comment